Category: Accuray Inc.
A federal judge in California dealt blows to both sides in a patent infringement dispute over spinal implant technology between several Medtronic Inc. (NYSE:MDT) subsidiaries and NuVasive Inc. (NSDQ:NUVA).
A former sales director for Exactech Inc. lands five years' probation and $56,000 in fines after pleading guilty to a kickbacks scheme with orthopedic surgeons.
A former sales rep for Exactech Inc. avoided prison but landed five years' probation and $56,000 in fines after pleading guilty to setting up a kickbacks scheme to encourage orthopedic surgeons to use the company's hip and knee implants.
Judge Garrett Brown of the U.S. District Court for New Jersey handed down the sentence to Douglas Donofrio, the former New York-area sales director for the Gainesville, Fla.-based company. Donofrio pleaded guilty to running the scheme between 2002 and 2008.
A federal judge in Pennsylvania tosses the charges against four former Best Medical International executives, accusing them of stealing trade secrets Accuray allegedly used to develop its CyberKnife device, but lets patent infringement charges stand against Accuray.
A federal judge tossed the charges against four former Best Medical International Inc. executives accusing them of stealing trade secrets, but let stand patent infringement charges against Accuray Corp. (NSDQ:ARAY).
Accuray CEO Euan Thomson outlines the path to integrating recently acquired TomoTherapy in an email to employees.
Accuray Inc.'s (NSDQ:ARAY) nearly $300 million deal to buy TomoTherapy Inc. (NSDQ:TOMO) isn't closed yet, but the integration of the two companies is already underway.
Accuray CEO Euan Thomson wrote in an email to employees that the company isn't officially beginning the process until the deal closes, but the Sunnyvale, Calif.-based CyberKnife radiosurgery device maker is already taking steps to ensure a smooth transition.
Accuray Inc. inks an acquisition deal for radiation therapy company TomoTherapy Inc. worth $277 million.
Accuray Inc. (NSDQ:ARAY) looks set to acquire radiation treatment firm TomoTherapy Inc. (NSDQ:TOMO) in a deal worth $277 million.
The Sunnyvale, Calif.-based radiosurgery company signed an agreement to buy TomoTherapy for $4.80 per share in cash and stock, a nearly 31 percent premium over its $3.67 closing price on Friday, March 4.
The companies believe their technologies complement one another in that they can serve overlapping patient populations.
Thoratec Corp. profits jump 58 percent and Accuray Inc. and Cepheid vault out of the red as Abaxis Inc., ResMed Inc., Uroplasty Inc., ZOLL Medical Corp., Solos Endoscopy Inc., Alcon Inc., Cardica Inc. and Omnicell Inc. all release their most recent quarterly sales and earnings numbers.
MassDevice keeps a close eye on public medical device companies, tracking their quarterly sales and earnings reports. For the most recent filings, check out our Earnings Roundup, where we collect each quarter's reports.
Here's a quick rundown of a few releases over the past couple days:
Accuray Inc. CEO Euan Thomson: uncertainty in the medical device space will likely remain a constant in 2011.
CEO, Accuray Inc.